BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 19278572)

  • 1. The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.
    Yan SF; Ramasamy R; Schmidt AM
    Expert Rev Mol Med; 2009 Mar; 11():e9. PubMed ID: 19278572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAGE and the pathogenesis of chronic kidney disease.
    D'Agati V; Schmidt AM
    Nat Rev Nephrol; 2010 Jun; 6(6):352-60. PubMed ID: 20421886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.
    Stern D; Yan SD; Yan SF; Schmidt AM
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1615-25. PubMed ID: 12453678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
    Stern DM; Yan SD; Yan SF; Schmidt AM
    Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.
    Schmidt AM; Stern DM
    Front Biosci; 2001 Oct; 6():D1151-60. PubMed ID: 11578972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.
    Ramasamy R; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2011 Dec; 1243():88-102. PubMed ID: 22211895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
    Basta G
    Atherosclerosis; 2008 Jan; 196(1):9-21. PubMed ID: 17826783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE in tissue homeostasis, repair and regeneration.
    Sorci G; Riuzzi F; Giambanco I; Donato R
    Biochim Biophys Acta; 2013 Jan; 1833(1):101-9. PubMed ID: 23103427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease.
    Bucciarelli LG; Wendt T; Rong L; Lalla E; Hofmann MA; Goova MT; Taguchi A; Yan SF; Yan SD; Stern DM; Schmidt AM
    Cell Mol Life Sci; 2002 Jul; 59(7):1117-28. PubMed ID: 12222959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis.
    Ramasamy R; Yan SF; Herold K; Clynes R; Schmidt AM
    Ann N Y Acad Sci; 2008 Apr; 1126():7-13. PubMed ID: 18448789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation.
    Moser B; Szabolcs MJ; Ankersmit HJ; Lu Y; Qu W; Weinberg A; Herold KC; Schmidt AM
    Am J Transplant; 2007 Feb; 7(2):293-302. PubMed ID: 17241110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on RAGE signaling and its role in cardiovascular disease.
    Cohen MM
    Am J Med Genet A; 2013 Nov; 161A(11):2750-5. PubMed ID: 24123885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress.
    Herold K; Moser B; Chen Y; Zeng S; Yan SF; Ramasamy R; Emond J; Clynes R; Schmidt AM
    J Leukoc Biol; 2007 Aug; 82(2):204-12. PubMed ID: 17513693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.
    Ramasamy R; Vannucci SJ; Yan SS; Herold K; Yan SF; Schmidt AM
    Glycobiology; 2005 Jul; 15(7):16R-28R. PubMed ID: 15764591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.
    Yan SF; D'Agati V; Schmidt AM; Ramasamy R
    Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding RAGE, the receptor for advanced glycation end products.
    Bierhaus A; Humpert PM; Morcos M; Wendt T; Chavakis T; Arnold B; Stern DM; Nawroth PP
    J Mol Med (Berl); 2005 Nov; 83(11):876-86. PubMed ID: 16133426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE)--an introduction.
    Thornalley PJ
    Mol Nutr Food Res; 2007 Sep; 51(9):1107-10. PubMed ID: 17854008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE: a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair.
    Rong LL; Gooch C; Szabolcs M; Herold KC; Lalla E; Hays AP; Yan SF; Yan SS; Schmidt AM
    Restor Neurol Neurosci; 2005; 23(5-6):355-65. PubMed ID: 16477098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
    Yan SF; Ramasamy R; Schmidt AM
    J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure.
    Ramasamy R; Schmidt AM
    Curr Heart Fail Rep; 2012 Jun; 9(2):107-16. PubMed ID: 22457230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.